High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families
- PMID: 1427902
- DOI: 10.1016/s0888-7543(05)80179-x
High-resolution physical mapping of four microsatellite repeat markers near the RYR1 locus on chromosome 19q13.1 and apparent exclusion of the MHS locus from this region in two malignant hyperthermia susceptible families
Abstract
Malignant hyperthermia susceptibility (MHS) is a potentially lethal, hereditary disorder of skeletal muscle that may be triggered by inhalation anesthetics and depolarizing muscle relaxants. Defects in the gene encoding the ryanodine receptor (RYR1) localized on human chromosome 19q13.1 have been proposed to be responsible for MHS. Using a chromosome 19-specific human/hamster somatic cell hybrid mapping panel, we were able to determine that four closely linked microsatellite repeat markers bracket RYR1 with the order 19cen-D19S75-D19S191-RYR1-(D19S47, D19S190)-19ter. Application of the four markers to genetic studies of MHS showed recombination between the markers and MHS in two families, with linkage analysis apparently excluding the MHS locus from the RYR1 region of 19q13.1. These results therefore support the recent observations of genetic heterogeneity in MHS.
Similar articles
-
Evidence for genetic heterogeneity of malignant hyperthermia susceptibility.Am J Hum Genet. 1992 Jun;50(6):1151-61. Am J Hum Genet. 1992. PMID: 1598899 Free PMC article.
-
Localization of the gene encoding the alpha 2/delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families.Hum Mol Genet. 1994 Jun;3(6):969-75. doi: 10.1093/hmg/3.6.969. Hum Mol Genet. 1994. PMID: 7951247
-
Genetic mapping of the beta 1- and gamma-subunits of the human skeletal muscle L-type voltage-dependent calcium channel on chromosome 17q and exclusion as candidate genes for malignant hyperthermia susceptibility.Hum Mol Genet. 1993 Jul;2(7):863-8. doi: 10.1093/hmg/2.7.863. Hum Mol Genet. 1993. PMID: 8395940
-
[What significance to genotype changes have in diagnosis of malignant hyperthermia?].Anasthesiol Intensivmed Notfallmed Schmerzther. 1996 Aug;31(6):334-43. doi: 10.1055/s-2007-995932. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996. PMID: 8962927 Review. German.
-
Ryanodine receptor mutations in malignant hyperthermia and central core disease.Hum Mutat. 2000;15(5):410-7. doi: 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D. Hum Mutat. 2000. PMID: 10790202 Review.
Cited by
-
Malignant-hyperthermia susceptibility is associated with a mutation of the alpha 1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle.Am J Hum Genet. 1997 Jun;60(6):1316-25. doi: 10.1086/515454. Am J Hum Genet. 1997. PMID: 9199552 Free PMC article.
-
Discordance, in a malignant hyperthermia pedigree, between in vitro contracture-test phenotypes and haplotypes for the MHS1 region on chromosome 19q12-13.2, comprising the C1840T transition in the RYR1 gene.Am J Hum Genet. 1995 Jun;56(6):1334-42. Am J Hum Genet. 1995. PMID: 7762556 Free PMC article.
-
Evidence for human meiotic recombination interference obtained through construction of a short tandem repeat-polymorphism linkage map of chromosome 19.Am J Hum Genet. 1993 Nov;53(5):1079-95. Am J Hum Genet. 1993. PMID: 8213834 Free PMC article.
-
Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1.Am J Hum Genet. 1995 Mar;56(3):684-91. Am J Hum Genet. 1995. PMID: 7887423 Free PMC article.
-
Refined genetic localization for central core disease.Am J Hum Genet. 1993 Feb;52(2):398-405. Am J Hum Genet. 1993. PMID: 8430700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources